Serum levels of angiopoietin-related growth factor are increased in metabolic syndrome
- 30 April 2011
- journal article
- Published by Elsevier BV in Metabolism
- Vol. 60 (4), 564-568
- https://doi.org/10.1016/j.metabol.2010.05.013
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Science and Technology (2009-0073513)
- National Research Foundation of Korea
This publication has 32 references indexed in Scilit:
- Cardiovascular Effects of Disturbed Insulin Activity in Metabolic Syndrome and in Type 2 Diabetic PatientsHormone and Metabolic Research, 2009
- Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosisClinical Endocrinology, 2008
- Serum Retinol-Binding Protein: A Link Between Obesity, Insulin Resistance, and Type 2 DiabetesNutrition Reviews, 2008
- The Metabolic Syndrome as a Concept of Adipose Tissue DiseaseHypertension Research, 2008
- Angiopoietin-Related Growth Factor Suppresses Gluconeogenesis through the Akt/Forkhead Box Class O1-Dependent Pathway in HepatocytesThe Journal of pharmacology and experimental therapeutics, 2007
- Angiopoietin-related growth factor (AGF) supports adhesion, spreading, and migration of keratinocytes, fibroblasts, and endothelial cells through interaction with RGD-binding integrinsBiochemical and Biophysical Research Communications, 2006
- Angiopoietin-like proteins: Another player in the metabolic fieldJournal of Hepatology, 2006
- The Prevalence of the Metabolic Syndrome in Korean Adults: Comparison of WHO and NCEP CriteriaYonsei Medical Journal, 2005
- Prevalence and clinical characteristics of metabolic syndrome in a rural population of South KoreaDiabetic Medicine, 2004
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001